8,508 matched individuals (mean age 42, 50% women).
💊 Chronic opioid use in 20.9% overall.
⚠️ Early TNFi = higher risk (HR 1.17, 95% CI 1.06–1.28).
Opioid-naïve: HR 1.96 🚨
Opioid-experienced: NS
8,508 matched individuals (mean age 42, 50% women).
💊 Chronic opioid use in 20.9% overall.
⚠️ Early TNFi = higher risk (HR 1.17, 95% CI 1.06–1.28).
Opioid-naïve: HR 1.96 🚨
Opioid-experienced: NS
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social